<DOC>
	<DOCNO>NCT02556554</DOCNO>
	<brief_summary>A single-center , prospective , 'open-label , ' investigator-initiated pilot study evaluate role continuous glucose monitor ( CGM ) use either alone remote monitor capability pregnancy associate T1DM .</brief_summary>
	<brief_title>Pilot Prospective CGM Quality Improvement ( QI ) Project Pregnancy</brief_title>
	<detailed_description>A single-center , prospective , 'open-label , ' investigator-initiated pilot study evaluate role continuous glucose monitor ( CGM ) use either alone remote monitoring capability enable subject share CGM data family friend ( investigator call `` follower '' protocol ) among woman T1DM associate pregnancy .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Signed informed consent studyrelated activity Female age 18 year old T1D duration &gt; 1 year Pregnancy confirmation gestational age 13 week less Willingness routinely practice least 37 blood glucose measurement per day Using MDI CSII therapy Willingness provide A1C level Ability willingness adhere protocol include schedule study visit duration pregnancy Able speak , read , write English Exclusion Criteria Extensive skin changes/diseases inhibit wear sensor normal skin Known allergy adhesive Any condition , determine investigator , could make subject unsuitable trial , impair subject 's suitability trial , impairs validity inform consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>